lapatinib ditosylate
Date：2021-12-20 Categories：Related Application Product
| post date: |
dec 19,2021 |
| expiry date: |
jun 17,2022 |
| detailed description: |
cas no. :388082-77-7
lapatinib ditosylate
388082-78-8 |
| cas registry number: |
388082-77-7
|
| synonyms: |
;benzenesulfonic acid;n-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6 -[5-[(2-methylsulfonylethylamino)methyl]-2-furyl]quinazolin-4-amine h ydrate;n-(3-chloro-4-((3-fluorophenyl)methoxy)phenyl)-6-(5-(((2-(methylsulfonyl)ethyl)amino)methyl)-2-furanyl)-4-quinazolinamine bis(4-methylbenzenesulfonate);tykerb n-{3-chloro-4-[(3-fluorophenyl)-methoxy]-phenyl}-6-{5-{(2-methylsulfonylethy amino)-methyl]-2-furyl}-quinazolin-4-amine-benzenesulfonic acid;lapatinib, tykerb, gw572016;n-{3-chloro-4-[(3-fluorobenzyl)oxy]phenyl}-6-[5-({[2-(methylsulfonyl)ethyl]amino}methyl)furan-2-yl]quinazolin-4-amine benzenesulfonate hydrate (1:2:1);lapatinib ditosylate anhydrous;benzenesulfonic acid;n-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[5-[(2-methylsulfonylethylamino)methyl]furan-2-yl]quinazolin-4-amine;hydrate;lapatinib ditoyslate;n-{3-chloro-4-[(3-fluorobenzyl)oxy]phenyl}-6-[5-({[2-(methylsulfonyl)ethyl]amino}methyl)furan-2-yl]quinazolin-4-amine bis(4-methylbenzenesulfonate); |
| molecular formula: |
c41h40clfn4o11s3 |
| molecular weight: |
915.4229 |
| molecular structure: |
|
